Edition:
United Kingdom

Hutchison China MediTech Ltd (HCM.OQ)

HCM.OQ on NASDAQ Stock Exchange Global Select Market

39.56USD
19 Jan 2018
Change (% chg)

-- (--)
Prev Close
$39.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,185
52-wk High
$42.00
52-wk Low
$12.67

Chart for

About

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

China cancer specialist Chi-Med plans $262 mln share offering

LONDON, Oct 25 China-based cancer and immunology drug specialist Hutchison China MediTech, or Chi-Med, said it aimed to offer $262 million of American Depositary Shares, subject to market conditions, to help fund development of its pipeline.

25 Oct 2017

BRIEF-Astrazeneca says co and Chi-med's Savolitinib shows encouraging clinical activity

* Astrazeneca and Chi-med’s Savolitinib shows encouraging clinical activity in 2nd-line EGFR mutation-positive lung cancer with met-amplification

17 Oct 2017

Earnings vs. Estimates